NAYA (NAYA Biosciences) קצב צמיחת רווח למניה בשנה הנוכחית
The annual EPS volatility reflects profit dynamics, where 92.70 indicates the current value of the metric. The financial profile of NAYA Biosciences (NAYA) is constrained by R&D expenses but protected by antibody patents. Its status as a scientific leader reinforces investor confidence in the development of multispecific proteins. The company's technologies are based on training the immune system to accurately recognize tumors, which helps combat aggressive forms of cancer.
פילוחי מדדים פיננסיים ומדדי שוק עבור NAYA Biosciences (NAYA)
Institutional capital assesses the attractiveness of NAYA Biosciences (NAYA) through the dynamics of profit generation efficiency. This relative annual growth in net income per share measures the percentage deviation of the current EPS from the value of the same period last year, revealing hidden profitability trends. The stability of this metric confirms the asset's reliability, reflecting financial resilience in organizing complex biomaterial logistics for oncology research.
